Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now […]
The US Food and Drug Administration (FDA) may be open to allowing CBD as an ingredient in dietary supplements as well as in food and drink products. However, the regulatory pathway is not clear
Investing activity in the cannabis space is on the rise, as investors take advantage of lower prices and companies seek opportunities to merge – bolstered by anticipated changes at US federal level
Well reported studies of labelling issues give unfair bad press to CBD – but it is an issue the industry urgently needs to address, according to speakers at the Food and Drug Law Institute’s annual conference
It remains unclear when, or whether, US FDA guidance on CBD enforcement policy will be published, according to speakers at the recent Food and Drug Law Institute annual conference
The National Advertising Division (NAD) of the US Better Business Bureau has referred advertising claims made by a CBD company to the Federal Trade Commission (FTC)
With US elections on 3rd November fast approaching, lobbyists for CBD, cannabis and hemp are eager to get their message across to candidates on both sides of the political divide
The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD
Should CBD or cannabis companies invest in the US or Canada? There are pros and cons to each, and the same answer may not apply to everyone – or remain the same forever
The US House of Representatives is expected to hold a historic vote this month on a comprehensive cannabis reform bill that supporters embrace for not only decriminalising marijuana but correcting injustices
More than a dozen CBD businesses have given their backing to an investigation of the impact of CBD on liver toxicity levels in order to provide regulatory authorities in the US with reliable new data
First it’s important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to be criticising aspects of the proposed regulatory regime that have raised hackles among the industry.
Proposed regulations from the US Drug Enforcement Administration (DEA) have riled the hemp and CBD sectors, with opinions divided on what the rule would mean if enacted in its current form
Charlotte’s Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share.
Canadian cannabinoid firm Canopy Growth has signed a multi-year deal with NFL quarterback Patrick Mahomes as part of its advance into the sports nutrition market
The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics Convention.
Clinical research guidance from the US Food and Drug Administration (FDA) should provide further impetus for cannabis research, which is certain to have an impact on the CBD market
Although opponents of the ban had their positive result overthrown by the Seventh Circuit Court of Appeals, the decision is not as bad as a headline might suggest.
The Seventh Circuit Court of Appeals has dealt a blow to challengers of Indiana’s smokable hemp ban, ruling that the lower court went too far in restricting the enforcement of Indiana’s ban
Hemp companies, politicians and legal experts have welcomed guidance from US monetary regulators that should drive up the number of financial institutions servicing the sector
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty
The company behind the world’s first injectable CBD product has issued a voluntary recall, while the US FDA continues to send warning letters over unsubstantiated health claims
With the federal legalisation of hemp in the US , states were left to enact their own legislation to adapt. CBD-Intel provides an overview of US law on smokable hemp, along with analysis of each state’s rules
The US Drug Enforcement Administration (DEA) has removed Epidiolex, the only CBD drug so far approved by the US Food and Drug Administration (FDA), from its list of controlled substances
The US Department of Agriculture (USDA) is to temporarily delay enforcement of two controversial provisions in its interim hemp production rule after receiving a large quantity of critical feedback
Leading members of the US Congress are again pushing for the legalisation of dietary supplements containing hemp-derived CBD, currently banned by the Food and Drug Administration (FDA)
Federal banking regulators have issued guidance clarifying the legal status of banks doing business with hemp firms, permitting it as long as they follow and comply with the relevant requirements of the Bank Secrecy Act
Expect to see more CBD-related lawsuits from individual US consumers over the next year – and increased litigation could help to speed up regulatory clarification
The US Department of Agriculture hemp rules have been published, developing the 2018 federal Farm Bill in time to offer guidance to farmers for the 2020 hemp growing season. This report provides in-depth information
Cannabis-based vaping products won’t be legally available in Canada’s second-largest province “for the time being” after the Quebec government-owned cannabis monopoly decided to keep them off the shelves
A “minibus spending package” in the US Senate will provide hemp stakeholders with protection as well as funding for further work by federal institutions in the sector
The US Department of Agriculture (USDA) has announced that it is preparing to release the interim final rules governing a national hemp product program
Despite various bodies making steps towards legalisation, the existing legal environment for CBD across the US remains a patchwork of contradictory policies
CBD and hemp regulation across the US remains mixed; this report takes the three main provisions of the 2018 US Farm Bill, and analyses each state’s implementation
US Senate majority leader Mitch McConnell is to attach funding to the agricultural appropriations bill to speed the FDA’s preliminary steps towards rulemaking for CBD products
Rising demand for hemp products could soon make it an important cash crop for America but both industry and regulators must change to meet evolving demands and challenges
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Regulatory report: medical and recreational cannabis – a global overview
CBD-Intel has compiled and classified the regulatory data on medical and recreational cannabis in 50 jurisdictions around the world.
The report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries using maps, and assesses the likelihood that the status quo may change in the future.
